Purchase of Diathermy
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £48,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33141530 |
| Deadline | 6 Nov 2023 |
| Contract start | 9 Nov 2023 |
| Contract end | 8 Nov 2024 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-76f7360e-b02a-4ed7-ac87-44427f71c36c |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Erbe Medical UK Ltd | £10,727 | 7 Nov 2023 | active |
description
Diathermy
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 20 Nov 2023 | Award (award) | · | 2144bbb2-0ed1-40c2-a441-9483d366ec95-699884 |
more from Leeds Teaching Hospitals NHS Trust
- Supply of Interventional Radiology & Interventional Cardiology Products · £506,534 · 11 Sept 2026
- Supply of Interventional Radiology & Interventional Cardiology Products · £1,240,154 · 8 Sept 2026
- Radiology Stents - carotid, iliac, renal and peripheral vascular stents · £183,400 · 8 Sept 2026
- Supply of Interventional Radiology & Cardiology Consumables · £4,989,200 · 7 Sept 2026
- Purchase of Diagnostic Ultrasound Scanners · £48,286 · 7 Sept 2026
- Purchase of Enteroscope · £49,177 · 4 Sept 2026
- Supply of Interventional Radiology Products · £762,462 · 4 Sept 2026
- Supply of Radiology Interventional Products · £2,903,771 · 4 Sept 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £130,000
- NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B · NHS England · £192,000,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £44,601
- National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders · NHS England · £302,000,000
- HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS · University Hospitals of North Midlands NHS Trust
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.